The effect of silk peptide on immune system, A randomized, double-blind, placebo-controlled clinical trial

Jin Taek Hwang, Jung Min Cho, In Hye Jeong, Jeong yong Lee, Ki Chan Ha, Hyang Im Baek, Hye Jeong Yang, Min Jung Kim, Jong Ho Lee

Research output: Contribution to journalArticle

Abstract

In this study, we evaluated the immunostimulatory effect of silk peptide in subjects with peripheral blood leukocyte levels of 4–8 × 10 3 /μl by a randomized, double-blind, placebo-controlled clinical trial. The subjects were randomly assigned to one of two groups, the placebo control or silk peptide intervention group, for 8 weeks. As a result, evaluation of efficacy in 97 subjects showed no significant difference between the groups in immunostimulatory parameters. However, after separate analysis of 61 non-season influenza vaccine subjects, the natural killer cell activity (%) with an effector cell: target cell (E: T) ratio of 10:1 was increased significantly from 30.7 ± 2.28% at week 0 to 41.8 ± 2.71% at week 8 (p < 0.01) in the silk peptide groups. In addition, IL-2, IL-12, and IFN-γ levels were increased in the silk peptide group and decreased in the placebo group. These results suggested that silk peptide is effective for enhancing immune activity.

Original languageEnglish
Pages (from-to)275-284
Number of pages10
JournalJournal of Functional Foods
Volume55
DOIs
Publication statusPublished - 2019 Apr 1

Fingerprint

Silk
Controlled Clinical Trials
silk
placebos
immune system
clinical trials
Immune System
Placebos
peptides
Peptides
Influenza Vaccines
interleukin-12
natural killer cells
Interleukin-12
interleukin-2
Natural Killer Cells
influenza
Interleukin-2
leukocytes
Leukocytes

All Science Journal Classification (ASJC) codes

  • Food Science
  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Hwang, Jin Taek ; Cho, Jung Min ; Jeong, In Hye ; Lee, Jeong yong ; Ha, Ki Chan ; Baek, Hyang Im ; Yang, Hye Jeong ; Kim, Min Jung ; Lee, Jong Ho. / The effect of silk peptide on immune system, A randomized, double-blind, placebo-controlled clinical trial. In: Journal of Functional Foods. 2019 ; Vol. 55. pp. 275-284.
@article{df48d19ae96d41e69e7a5638fd61465f,
title = "The effect of silk peptide on immune system, A randomized, double-blind, placebo-controlled clinical trial",
abstract = "In this study, we evaluated the immunostimulatory effect of silk peptide in subjects with peripheral blood leukocyte levels of 4–8 × 10 3 /μl by a randomized, double-blind, placebo-controlled clinical trial. The subjects were randomly assigned to one of two groups, the placebo control or silk peptide intervention group, for 8 weeks. As a result, evaluation of efficacy in 97 subjects showed no significant difference between the groups in immunostimulatory parameters. However, after separate analysis of 61 non-season influenza vaccine subjects, the natural killer cell activity ({\%}) with an effector cell: target cell (E: T) ratio of 10:1 was increased significantly from 30.7 ± 2.28{\%} at week 0 to 41.8 ± 2.71{\%} at week 8 (p < 0.01) in the silk peptide groups. In addition, IL-2, IL-12, and IFN-γ levels were increased in the silk peptide group and decreased in the placebo group. These results suggested that silk peptide is effective for enhancing immune activity.",
author = "Hwang, {Jin Taek} and Cho, {Jung Min} and Jeong, {In Hye} and Lee, {Jeong yong} and Ha, {Ki Chan} and Baek, {Hyang Im} and Yang, {Hye Jeong} and Kim, {Min Jung} and Lee, {Jong Ho}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.jff.2019.02.032",
language = "English",
volume = "55",
pages = "275--284",
journal = "Journal of Functional Foods",
issn = "1756-4646",
publisher = "Elsevier Limited",

}

The effect of silk peptide on immune system, A randomized, double-blind, placebo-controlled clinical trial. / Hwang, Jin Taek; Cho, Jung Min; Jeong, In Hye; Lee, Jeong yong; Ha, Ki Chan; Baek, Hyang Im; Yang, Hye Jeong; Kim, Min Jung; Lee, Jong Ho.

In: Journal of Functional Foods, Vol. 55, 01.04.2019, p. 275-284.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of silk peptide on immune system, A randomized, double-blind, placebo-controlled clinical trial

AU - Hwang, Jin Taek

AU - Cho, Jung Min

AU - Jeong, In Hye

AU - Lee, Jeong yong

AU - Ha, Ki Chan

AU - Baek, Hyang Im

AU - Yang, Hye Jeong

AU - Kim, Min Jung

AU - Lee, Jong Ho

PY - 2019/4/1

Y1 - 2019/4/1

N2 - In this study, we evaluated the immunostimulatory effect of silk peptide in subjects with peripheral blood leukocyte levels of 4–8 × 10 3 /μl by a randomized, double-blind, placebo-controlled clinical trial. The subjects were randomly assigned to one of two groups, the placebo control or silk peptide intervention group, for 8 weeks. As a result, evaluation of efficacy in 97 subjects showed no significant difference between the groups in immunostimulatory parameters. However, after separate analysis of 61 non-season influenza vaccine subjects, the natural killer cell activity (%) with an effector cell: target cell (E: T) ratio of 10:1 was increased significantly from 30.7 ± 2.28% at week 0 to 41.8 ± 2.71% at week 8 (p < 0.01) in the silk peptide groups. In addition, IL-2, IL-12, and IFN-γ levels were increased in the silk peptide group and decreased in the placebo group. These results suggested that silk peptide is effective for enhancing immune activity.

AB - In this study, we evaluated the immunostimulatory effect of silk peptide in subjects with peripheral blood leukocyte levels of 4–8 × 10 3 /μl by a randomized, double-blind, placebo-controlled clinical trial. The subjects were randomly assigned to one of two groups, the placebo control or silk peptide intervention group, for 8 weeks. As a result, evaluation of efficacy in 97 subjects showed no significant difference between the groups in immunostimulatory parameters. However, after separate analysis of 61 non-season influenza vaccine subjects, the natural killer cell activity (%) with an effector cell: target cell (E: T) ratio of 10:1 was increased significantly from 30.7 ± 2.28% at week 0 to 41.8 ± 2.71% at week 8 (p < 0.01) in the silk peptide groups. In addition, IL-2, IL-12, and IFN-γ levels were increased in the silk peptide group and decreased in the placebo group. These results suggested that silk peptide is effective for enhancing immune activity.

UR - http://www.scopus.com/inward/record.url?scp=85062059408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062059408&partnerID=8YFLogxK

U2 - 10.1016/j.jff.2019.02.032

DO - 10.1016/j.jff.2019.02.032

M3 - Article

VL - 55

SP - 275

EP - 284

JO - Journal of Functional Foods

JF - Journal of Functional Foods

SN - 1756-4646

ER -